UBS AM’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $737K | Buy |
+25,155
| New | +$737K | ﹤0.01% | 2442 |
|
2022
Q2 | – | Sell |
-34,493
| Closed | -$1.23M | – | 2784 |
|
2022
Q1 | $1.23M | Sell |
34,493
-2,182
| -6% | -$77.9K | ﹤0.01% | 2025 |
|
2021
Q4 | $3.19M | Sell |
36,675
-26,568
| -42% | -$2.31M | ﹤0.01% | 1636 |
|
2021
Q3 | $7.26M | Buy |
63,243
+6,988
| +12% | +$802K | ﹤0.01% | 1216 |
|
2021
Q2 | $12.1M | Buy |
+56,255
| New | +$12.1M | 0.01% | 1053 |
|